The present systematic review evaluated the overall effect of mTOR polymorphisms on cancer risk, and the updated meta-analysis evaluated the most commonly investigated mTOR polymorphisms: rs2536, rs2295080, rs1883965, rs1034528, rs17036508, rs3806317 and rs1064261. Here, MTOR is linked to cancer.